Novel antiplatelet targets in the treatment of acute coronary syndromes
FO Alenazy, MR Thomas - Platelets, 2021 - Taylor & Francis
Acute coronary syndromes (ACS) are a global cause of mortality and morbidity that affect
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
Novel antiplatelet targets in the treatment of acute coronary syndromes
FO Alenazy, MR Thomas - Platelets, 2021 - pubmed.ncbi.nlm.nih.gov
Acute coronary syndromes (ACS) are a global cause of mortality and morbidity that affect
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
Novel antiplatelet targets in the treatment of acute coronary syndromes.
FO Alenazy, MR Thomas - Platelets, 2020 - europepmc.org
Acute coronary syndromes (ACS) are a global cause of mortality and morbidity that affect
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
Novel antiplatelet targets in the treatment of acute coronary syndromes.
FO Alenazy, MR Thomas - Platelets, 2021 - search.ebscohost.com
Acute coronary syndromes (ACS) are a global cause of mortality and morbidity that affect
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …
millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and …